Clinical study for the 'Wen-Yang Tong-Du' medicine pot in the treatment of ankylosing spondylitis

Gansu Provincial Hospital of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the diagnostic criteria for ankylosing spondylitis in Western medicine;
•2. those who meet the syndrome of kidney deficiency and cold syndrome;
•3. aged between 18 and 40 years old, low back pain for at least 3 months;
•4. disease activity >=4 weeks;
•5. BASDAI score >4 points;
•6. arthritis: bilateral II ~ IV or unilateral III ~ IV or MRI suggest ankle joint active (acute) inflammation;
•7. Volunteer to participate in the trial and agree to enter the clinical study and sign the informed consent form.

•1. pregnant or lactating women and allergic to this drug;
•2. combined with severe primary diseases such as cerebrovascular, cardiovascular, liver, kidney and hematopoietic system, and mental patients;
•3. active infection, lower extremity ulcer, tuberculosis, natural joint or artificial joint septic arthritis within 12 months, and persistent or recurrent pulmonary infection or urinary catheter;
•4. In the late stage, the spine was severe, the joints were severely deformed, stiff, and lost labor;
•5. other seronegative spondyloarthropathy, or patients with other rheumatism;
•6. patients with impaired skin integrity, is not suitable for cupping treatment.

发起方

Gansu Provincial Hospital of TCM